Novel and scalable approach to research grade AAV vector manufacturing and separation of distinct AAV serotypes

被引：0
|
作者：
Toelen, Jaan [1 ]
Lock, Martin [2 ]
Vandenberghe, Luk [2 ]
Carlon, Marianne [1 ]
Wilson, James [2 ]
Debyser, Zeger [1 ]
机构：
[1] Catholic Univ Louvain, B-3000 Louvain, Belgium
[2] Univ Penn, Gene Therapy Program, Dep Path & Lab Med, Philadelphia, PA 19104 USA
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1435 / 1435
页数：1
相关论文
共 50 条
  • [1] Novel Approach to Intermediate Scale AAV Vector Manufacturing and Separation of Distinct AAV Entities on Iodixanol Gradients
    Lock, Martin
    Toelen, Jaan
    Vandenberghe, Luk H.
    Alvira, Maruicio
    Samanta, Arabinda
    Debyser, Zeger
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2009, 17 : S272 - S273
  • [2] Evaluation of a Scalable Harvest Protocol Using a Panel of AAV Serotypes with Attention to Recombinant AAV Vector Integrity and Functionality
    Strasser, Kimchi A.
    Mancilla, Igor Alves
    Aichner, Sonja
    Meyer-Berg, Helena
    Huber, Georg
    Bauer, Jana
    Ferreira, Irene
    Salomon, Michael
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 443 - 443
  • [3] Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing
    Selvaraj, Nagarathinam
    Wang, Chao-Kuei
    Bowser, Brian
    Broadt, Trevor
    Shaban, Samir
    Burns, Jenna
    Saptharishi, Nirmala
    Pechan, Peter
    Golebiowski, Diane
    Alimardanov, Asaf
    Yang, Nora
    Mitra, George
    Vepachedu, Ramarao
    [J]. HUMAN GENE THERAPY, 2021, 32 (15-16) : 850 - 861
  • [4] A highly scalable baculovirus-based process to manufacture AAV vector of various serotypes
    Ramirez, A.
    Steel, M.
    Jing, F.
    Woodburn, K.
    Vijay, S.
    Keravala, A.
    Chavez, C.
    Gasmi, M.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A164 - A164
  • [5] Development of a Scalable platform for AAV manufacturing
    Soula, A.
    Guenat, J.
    Bazot, Q.
    Weeratunge, N.
    Li, N.
    Kheir, T. Bou
    Thwaites, T.
    Delahaye, M.
    Berger, G.
    Kerby, J.
    Appleby, J.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A34 - A34
  • [6] Meeting Market Needs with Scalable AAV Manufacturing
    Vallanti, Giuliana
    Neri, Margherita
    Bellintani, Francesca
    Ungari, Sylvia
    Simonetti, Emanuele
    Meraviglia, Veronica
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 403 - 403
  • [7] Meeting Market Needs with Scalable AAV Manufacturing
    Neri, M.
    Bellinatani, F.
    Rossetti, F.
    Ungari, S.
    Simonetti, E.
    Meraviglia, V.
    Vallanti, G.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A115 - A115
  • [8] IsoTag AAV - An Innovative, Scalable, Non-Chromatographic Method for Streamlined AAV Manufacturing
    Dzuricky, Michael
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 13 - 13
  • [9] IsoTag™ AAV - An Innovative, Scalable, and Non-Chromatographic Method for Streamlined AAV Manufacturing
    Haley, J.
    Jones, J. B.
    Callander, M.
    Dzuricky, M.
    Luginbuhl, K.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A38 - A38
  • [10] Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids
    Booth, MJ
    Mistry, A
    Li, X
    Thrasher, A
    Coffin, RS
    [J]. GENE THERAPY, 2004, 11 (10) : 829 - 837
12345